PharmaResearch Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - PharmaResearch Co Ltd

Watchlist Manager

Watchlist

Price: 297 000 KRW -0.67% Market Closed

Market Cap: ₩3.1T

P	PharmaResearch Co Ltd KOSDAQ:214450	KR
	Kingstone Companies Inc NASDAQ:KINS	US
D	Dr Reddy's Laboratories Ltd BSE:500124	IN
C	Credit Agricole SA DUS:XCA	FR
C	CD Projekt SA WSE:CDR	PL
	Fastly Inc NYSE:FSLY	US
P	Pacific Industrial Co Ltd TSE:7250	JP
	Great Elm Capital Corp NASDAQ:GECC	US
	Context Therapeutics Inc NASDAQ:CNTX	US
	ACC Ltd NSE:ACC	IN
	Macfarlane Group PLC LSE:MACF	UK
	Haw Par Corporation Ltd SGX:H02	SG
	Canadian Natural Resources Ltd TSX:CNQ	CA
M	Mr Price Group Ltd JSE:MRP	ZA

Profitability Summary

PharmaResearch Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

77%

Strong 3Y Average Gross Margin

73%

Gross Margin is Increasing

73% > 77%

Exceptional Operating Margin

40%

Strong 3Y Average Operating Margin

36%

Operating Margin is Increasing

32% > 40%

Exceptional Net Margin

31%

Sustainable 3Y Average Net Margin

28%

Net Margin is Increasing

24% > 31%

Exceptional Free Cash Flow Margin

27%

Strong 3Y Average Free Cash Flow Margin

23%

Free Cash Flow Margin is Increasing

19% > 27%

Exceptional ROE

27%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

26%

ROIC is Increasing

19% > 40%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.